Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Annals of Surgical Oncology|February 20, 2015
Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After PancreatectomyLilian Schwarz, Morgan Bruno, Nathan H Parker, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 26, 2022
A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trialGenki Watanabe, Yoshihiro Mise, Masaru Oba, et al.Annals of Surgical Oncology|June 10, 2025
Robotic Central Pancreatectomy with Omental Pedicle Flap: Tactics and TipsFumihiro Kawano, Megan A Lim, Helen J Kemprecos, et al.Annals of Surgical Oncology|December 17, 2025
A Widely Applicable CAD-Based Intraoperative 3D Navigation Method for Hepatopancreatobiliary SurgeryRyota Ito, Atsushi Oba, Hayato Baba, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 24, 2015
After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant ReadmissionsYoshihiro Mise, Ryan W Day, Jean-Nicolas Vauthey, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 29, 2025
Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastasesAya Maekawa, Kojiro Omiya, Atsushi Oba, et al.Annals of Surgical Oncology|September 6, 2025
Cone Unit-Based Anatomical Liver Resection Guided by Preoperative Embolization and ICG Fluorescence: A Novel Surgical StrategyFumihiro Kawano, Megan A Lim, Helen J Kemprecos, et al.Annals of Surgical Oncology|June 10, 2020
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)Yoshihiro Mise, Kiyoshi Hasegawa, Akio Saiura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 7, 2019
Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver diseaseYuzuru Sakamoto, Sachiyo Yoshio, Hiroyoshi Doi, et al.International Journal of Cancer|March 24, 2016
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomyHiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, et al.Pageof 14